Skip to main content

Montreal Heart Institute to Use $5.1M Grant on PGx Studies for ACS Drug

NEW YORK (GenomeWeb News) — The Montreal Heart Institute has been awarded a CAN$5 million ($5.1 million) grant to fund a research project based on its academic and private partnerships in pharmacogenomics, MHI said late last week.
 
The funding was awarded as part of a Genome Quebec competition aimed at fostering public and private participation in developing personalized medical technologies.
 
As GenomeWeb Daily News reported last week, MHI will partner with VIA Pharmaceuticals to perform genomics and proteomics studies and to develop a genotyping panel that the company could use in Phase II clinical trials for an acute coronary syndrome drug.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.